No. 21-202 |
|
Title: |
Mylan Laboratories Ltd., Petitioner v. Janssen Pharmaceutica, N.V., et al. |
Docketed: | August 12, 2021 |
Lower Ct: | United States Court of Appeals for the Federal Circuit |
Case Numbers: | (2021-1071) |
Decision Date: | March 12, 2021 |
Aug 09 2021 | Petition for a writ of certiorari filed. (Response due September 13, 2021) Petition Appendix Certificate of Word Count Proof of Service |
Aug 18 2021 | Motion to extend the time to file a response from September 13, 2021 to October 12, 2021, submitted to The Clerk. Main Document |
Aug 19 2021 | Motion to extend the time to file a response is granted and the time is extended to and including October 12, 2021, for all respondents. |
Aug 25 2021 | Brief amicus curiae of Jeremy C. Doerre in support of neither party filed. Main Document Certificate of Word Count Proof of Service |
Sep 13 2021 | Brief amicus curiae of Association for Accessible Medicines filed. Main Document Certificate of Word Count Proof of Service |
Sep 13 2021 | Brief amicus curiae of Intel Corporation filed. Main Document Certificate of Word Count Proof of Service |
Sep 30 2021 | Motion to extend the time to file a response from October 12, 2021 to November 2, 2021, submitted to The Clerk. Main Document |
Oct 01 2021 | Motion to extend the time to file a response is granted and the time is further extended to and including November 2, 2021, for all respondents. |
Nov 02 2021 | Brief of Federal Respondent in opposition filed. Main Document Proof of Service |
Nov 02 2021 | Brief of respondent Janssen Pharmaceutica NV in opposition filed. Main Document Proof of Service Certificate of Word Count |
Nov 16 2021 | DISTRIBUTED for Conference of 12/3/2021. |
Nov 16 2021 | Reply of petitioner Mylan Laboratories Ltd. filed. (Distributed) Main Document Certificate of Word Count Proof of Service |
Nov 23 2021 | Rescheduled. |
Dec 29 2021 | DISTRIBUTED for Conference of 1/14/2022. |
Jan 18 2022 | Petition DENIED. Justice Alito took no part in the consideration or decision of this petition. |